The first quarter of 2026 has brought a surge in successful clinical outcomes for intranasal vesicle therapies aimed at chronic neurological decline. Following a landmark policy update by the World Health Organization, these non-invasive protocols are being fast-tracked for Alzheimer’s patients across international memory care networks. The 2026 focus is on utilizing these "biological...